Amgen Shadow Pricing Of Enbrel Under Scrutiny At US House Hearing

 
• By Jessica Merrill
  
Shadow
US Congress took issue with industry "shadow pricing" • Source: Shutterstock

More from Pricing Debate

More from Market Access